A Study of ALTY-0501 for the Treatment of Dry Eye Administered 4 Times a Day for a 56 Day Period
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to assess the safety and efficacy of doxycycline 0.025%
(ALTY-0501) ophthalmic solution for the treatment of dry eye using the Controlled Adverse
Environment (CAE) Model.